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Duchenne muscular dystrophy (DMD) is an inherited disorder characterized by 
rapidly progressive muscle weakness, which start in the legs and pelvis and later affects the 
whole body. The responsible gene for DMD has been mapped on the Xp21, namely 
dystrophin gene. This gene is the largest gene in human being, comprises 79 exons. The 
function of the gene is to enable muscle fibers to make a protein called dystrophin protein. 
Muscle fibers in people affected with DMD are extremely deficient of dystrophin protein. 
Seven exons were found to be the most commonly deleted in patients from South East Asia 
populations and we choose these seven exons for this study. The seven exons are exon 44, 
43, 45, 46, 49, 50, and 51. Seven DMD patients from Malaysia were recruited as our 
patients of study. Sec of blood were taken from these patients, DNA were extracted using 
kit (QiaAMP mini kit). Polymerase Chain Reaction (PCR) was performed to analyze the 
mutation of dystrophin gene in DMD patients. The objective is to detect the deletion of the 
seven hotspot exons of the dystrophin gene. We found that the two patients with deletion of 
all the tested exons. Three patients had at least two deleted while two did not show deletion 
of any of the seven exons tested. The two patients who did not show any deletion could not 
be excluded from DMD, as there could be other types of mutation in the Dystrophin gene, 
which is not tested in this study. 
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ABSTRAK 
Penyakit distrofi otot Duchenne (DMD) adalah penyakit keturunan yang dikenal 
pasti apabila berlakunya kelemahan fungsi otot dengan cepat terutama pada bahagian kaki 
dan pelvis. Gen yang terlibat ialah gen distrofin yang dipetakan pada kromosom X, Xp21. 
Gen ini adalah gen yang terbesar dalam badan manusia, mengadungi 79 exon. Tujuh 
daripada 79 exon ini telah dikenal pasti sebagai exon yang sering terhapus dan 
menyebabkan DMD bagi populasi pesakit DMD di bahagian Asia Tenggara iaitu exon 43, 
44, 45, 46, 49, 50, dan 51. Tujuh exon ini digunakan bagi menjayakan kajian ini. Gen 
clistrofin diperlukan untuk menghasilkan protein clistrofin yang berfungsi dalam 
menguatkan otot- otot. Gentian otot bagi pesakit DMD didapati mengalami kekurangan 
protein distrofin yang sangat teruk. Subjek bagi kajian ini ialah pesakit DMD dari seluruh 
Malaysia. Sec darah diambil dari pesakit. Pengekstratan DNA dilakukan menggunakan kit. 
'Polymerase Chain Reaction (PCR) digunakan untuk menggadakan gen tersebut dan 
sekaligus melakukan analisa. Objektif bagi kajian ini ialah mengenal pasti exon yang 
terhapus di antara tujuh 'hotspot' exon berdasarkan kajian- kajian yang lepas. Kami dapati 
dua pesakit yang diuji mempunyai exon yang terhapus bagi semua exon yang diuji. Tiga 
pesakit lagi mempunyai sekurang- kurangnya 2 exon yang terhapus manakala 2 pesakit lagi 
tidak mempunyai sebarang ex on yang terhapus. W alaubagaimanapun, dua pesakit yang 
tidak mempunyai sebarang exon yang terhapus tidak sepatutnya dikecualikan dari DMD 
kerana mungkin terdapat mutasi lain yang tidak diuji dalam kajian ini. 
X 
1.0 INTRODUCTION 
Muscular Dystrophy is a group of muscle diseases, which have three features in 
common. The features of muscular dystrophies are hereditary, progressive and each causes 
selective pattern of weakness. There are more than 20 types of muscular dystrophy such as 
Duchenne Muscular Dystrophy (DMD), Becker Muscular Dystrophy (BMD), Myotonic 
Dystrophy, Limb-girdle Muscular Dystrophy, Facioscapulohumeral Muscular Dystrophy, 
Spinal Muscular Atrophy (SMA) and others. All types of muscular dystrophy will 
gradually weaken the body's muscles. The different types of muscular dystrophy caused by 
different sets of muscle result in different degree of muscle weakness. More severe damage 
sets of muscle will produce more severe types of muscular dystrophy. To date, there is no 
cure for muscular dystrophy but to prevent and treat the conditions. There are so many 
researches done in diagnosis of muscular dystrophy as well as the classification and to 
prevent the condition. 
Muscular dystrophy caused by incorrect or missing genetic information that 
prevents the body from making the proteins it needs to build and maintain healthy muscle. 
Incorrect or missing genetic information could be caused by inheritance. For example, gene 
of muscular dystrophy such as Spinal Muscular Atrophy is an autosomal recessive. 
However, in some cases, children affected with muscular dystrophy disease have no family 
history of muscular dystrophy. They are born with abnormal genes that produce abnormal 
proteins. Several types of muscular dystrophy are listed in Table 1. 
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Table 1: Types of muscular dystrophy 
Types 
1) Duchenne Muscular Dystrophy 
Summary 
- Occurs because of absent of dystrophin 
protein due to abnormal dystrophin gene. 
- Affect mainly boys with 1 :3500 boys 
worldwide. 
- X-liked recessive disease. 
- Showed Gower's sign. 
- Symptoms usually appear around age 5, as 
2 
the pelvic muscles begin to weaken. 
The most common and severe form of 
muscular dystrophy. 
2) Becker Muscular Dystrophy 
3) Myotonic Dystrophy 
- Similar types with Duchenne Muscular 
Dystrophy. 
- Caused insufficient production of 
dystropbin protein due to abnormal 
dystrophin gene. 
- Affect mainly boys with 1 :30,000 boys 
worldwide. 
- X -linked recessive disease. 
- Muscle weakness first begins in the pelvic 
muscles, and then moves into the shouldes 
and back. 
Less severe than DMD. 
- Most common adult form of muscular 
dystrophy. 
- Caused by a portion of particular gene that 
is larger than it should be. 
- Symptoms: Myotonia (muscles have 
3 
trouble relaxing once contract), muscle 
weakness, muscle wasting. 
4) Limb-girdle Muscular Dystrophy 
5) Facioscapulohumeral Muscular 
- Affects boys and girls equally. 
- Symptoms begin when kids are between 8 
and 15 years old. 
- Muscle dystrophy progresses slowly. 
- Affecting the pelvic, shoulder and back 
muscles. 
- Can affect both boys and girls. 
- Symptoms usually first appear during the 
teen ages. 
- Muscle weakness first develops in the face. 
- Shoulders and back muscles gradually 
become weak, affected kids usually have 
difficulty lifting objects or raising their 
hands overhead. 
Among all muscular dystrophy, Duchenne muscular dystrophy is the most common 
and most severe type of muscular dystrophy (Chandrasoma and Taylor, 1995). Duchenne 
Muscular Dystrophy is an inherited disorder characterized by rapidly progressive muscle 
weakness, which start in the legs and pelvis and later affects the whole body. Duchenne 
muscular dystrophy and Becker muscular dystrophy is one of the most common X-linked 
4 
lethal genetic diseases. These two types of muscular dystrophy are cause by the mutation of 
same gene, which is dystrophin gene. 
Duchenne Muscular Dystrophy is first described by the French neurologist 
Guillaume Benjamin Amand Duchenne (1806-1875). He also described the nervous and 
muscular disorder. Although Edward Meryon had recognized similar cases with Duchenne 
muscular dystrophy 10 years early, Duchenne got the popularity based on his articles and 
illustrations on the same types of muscular dystrophy. Duchenne Muscular Dystrophy 
(DMD) is one of the muscular dystrophies characterized by the enlargement of muscle and 
rapid progression of muscle degradation that occurs early in life, as early as age three. 
DMD affects only males with rare exception in ratio 1 :3500 boys worldwide (Harper, 
1989). In 1950's, German doctor, Peter Emil Becker has studied the variant of Duchenne 
muscular dystrophy and described Becker muscular dystrophy, which is much milder 
version of DMD. Becker muscular dystrophy (BMD) is one of the muscular dystrophy, 
which has similar clinical features with Duchenne muscular dystrophy. BMD affects 
mainly males in ratio 1:222 (Emery et al., 1991). Both Duchenne and Becker muscular 
dystrophy are the most severe muscular diseases. 
In DMD, boys begin to show signs of muscle weakness as early as age 3. Usually 
kids with DMD will begin to show the symptoms at 5, as the pelvic muscles begin to 
weaken. By the 1880s, the English neurologist Sir William Gowers was able to identify 81 
clinical case reports confirming the clinical features established by Duchenne. Later, the 
sign that showed only by DMD patient was called Gower's sign (Sinha et al., 1992). 
Gower's sign is the sign that showed by DMD patients when they want to stand up from 
flat position. Other signs are fall often, late in learning to walk, enlarge calf muscle, poorly 
developed of other muscles, typical style of walk called waddling (Pradhan and Mittal, 
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1995). Children also showed toe walk, which is walk on the toes without the heels hitting 
the floor. The diseases usually weaken the skeletal or voluntary muscles, those in the anns, 
legs and trunk. A child may start to struggle to get up from the sitting positions or have a 
hard time to pushing things, like a tricycle or a wagon. Most of the children will need to use 
a wheelchair by the age of twelve. By the early teens or even earlier, the boy's heart and 
respiratory muscles may also affected. By age late teens or twenties, the condition of DMD 
is severe enough to shorten life expectancy. Kids with DMD also experienced less 
intelligence and mental retardation, however one third of them may have an average 
intelligence with others children. Before development of molecular analysis, Duchenne 
muscular dystrophy was diagnosis by the clinical features that showed by the patients. 
Sometimes, clinicians misdiagnose the similar types of muscular dystrophy such as 
Duchenne and Becker muscular dystrophy. However, clinical features also important to 
proceed any diagnosis especially molecular analysis and any others lab test such as muscle 
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Figure 1: Gower' s sign 
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DMD affect mainly on male because female have two X.,.chromosome, which make 
them secure from the disease but could be act as a carrier with no symptoms. Females 
normally have two X chromosomes, one of which contains a normal, dominant copy of the 
gene that will make enough of the protein for them to avoid symptoms. Women who carry 
the defective gene can pass an abnormal X chromosome to their sons. Since boys have an X 
chromosome from their mother and a Y chromosome from their father, there is no second 
X chromosome to make up for the defective gene from the carrier mother. Daughters of 
men with Duchenne muscular dystrophy will always be carriers, since they will inherit an 
affected X chromosome from their father 
Almost half of the DMD cases nowadays, the faulty gene was arisen from the 
mutation of the dystrophin gene in the boys itself, no other family members carriers. If the 
mother is a carrier, the risk to get an effected son is 50%. In the same cases, 50% of the 
daughters will be a carrier. The chance to get a normal son or daughter is also 50%. In some 
female cases, DMD is caused by skewed X chromosome inactivation. In these cases, two 
copies of the X chromosome exist, but for reasons currently unknown, the flawed X 
chromosome manifests instead of the unflawed copy. In these cases, a mosaic form of 
DMD is seen, in which some muscle cells are completely normal while others exhibit 
classic DMD fmdings. The effects of a mosaic form of DMD on long-term period of time is 
still not known. The best thing to do soon after knowing any of the family members were 
affected is to seek for genetic advice and appropriate test for the carrier in the family 
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Figure 2: X-linked inheritance 
DMD occurs when there are mutations of the dystrophin gene. Dystrophin gene 
located on the X chromosome with specific locus Xp21.1. Dystrophin gene is the largest 
gene in human being with 2.3 million base pair. DMD caused by several types of 
mutations, namely deletions, duplications and point mutations. Deletions accounted for the 
50-60% of mutation within the 79 exons of dystrophin gene (Scriver et al., 1995). 
Multiplex polymerase chain reaction (PCR) can be used to detect 98% of the deletion 
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(Beggs et al., 1990; Chamberlain et al., 1990). Large duplication and point mutation was 
the other causes ofDMD instead deletion (Read et al., 1988; Tennyson et al., 1995). 
Dystrophin gene encoded dystrophin protein, which important to keep muscle cells 
intact and work properly. Dystrophin protein links actin filaments to a complex of a 
transmembrane protein hence to the extracellular matrix. Mutations that affected the C-
terminus or actin-binding region cause Duchenne muscular dystrophy while mutations that 
shorten a helix cause Becker muscular dystrophy. Absent of dystrophin protein will lead to 
muscle damage due to produce of permeable membrane. Figure 3 shows the function of 







Figure 3: Function of dystrophin gene in the muscles. 
DMD can be diagnosed by measuring the serum creatine kinase level (SCK), 
muscle biopsy, clinical examination with taking a patient and family history and the most 
accurate test is molecular analysis or DNA analysis. In Malaysia, DMD can be diagnosed 
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by measunng the serum creatine kinase level (CK), muscle biopsy, and clinical 
examination. 
Molecular analysis of the dystrophin gene has only recently been introduced. 
Human Genome Center, School of Medical Sciences, Science University of Malaysia was 
the first center that does the molecular analysis of the dystrophin gene through this 
research. Molecular analysis of DMD could help us to confirm this disease although there 
is no cure for DMD till the time of writing. Figure 4 shows X chromosome with the locus 
of dysrtrophin gene. 
DMD 
Duchenne m uscular 
dystrophy 
IL2RG 
X -linked severe combined 
immunodeficiency (SCID) 
HPRT1 
Lesch - Nyh a n syndrome 
FMR1 
Fragile X syndrome 
MECP2 
R e tt syndrome 
PIG-A 





Alport s yndrome 
TNFSF5 
I mm u nod e'fici en cy 
with hyper-lgM 
ALD 
A dre n ole u ko dystrophy 
HEMA 
H e mophilia A 
Figure 4: The structure of X chromosome. 
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2.0 LITERATURE REVIEW 
2.1 Duchenne Muscular Dystrophy 
2 .1.1 Features 
Duchenne Muscular Dystrophy (DMD) is one of the most prevalent types of 
muscular dystrophy and characterized by rapid progression of muscle degradation that 
occurs early in life. DMD is also known as pseudohypertrophic muscular dystrophy. In 
common, DMD patients started to show the sign as early as age two. By the aged of twelve. 
most of the patients need a wheelchair to support them to move around. The sign shown by 
DMD patients is called the Gower's sign. 
Chandrasoma and Tylor 1995 
2.1.2 Ratio 
All are X-linked recessive and affect mainly males,an estimated 1 in 3500 boys 
worldwide. 
http://www.ncbi.nlm.nih . gov/books/bv .fcgi 
2.1.3 Dystrophin protein 
Dystrophin protein links actin filaments to a complex of a transmembrane protein 
hence to the extracellular matrix. Mutations that affected the C-terminus or actin-binding 
region cause Duchenne muscular dystrophy while mutations that shorten ex. helix cause 
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Becker muscular dystrophy. Absent of dystrophin protein will lead to muscle damage due 
to produce of permeable membrane. 
http://www.mdaorg.au/soecific/mdadmd.html 
2.2 Molecular Analysis 
2.2.1 X-chromosome 
Dystrophin gene located on the X chromosome with specific locus Xp21.1, is the 
largest gene in human being with 2.3 million base pair, comprises of 79 exons. 
Emery eta/., 1991 
2.2.2 Types of mutation 
There are several types of mutation in DMD patients, which are deletion, 
duplication and point mutation. Within this mutations, deletion accounted for two third of 
all DMD mutations, followed by large duplication and point mutation. Deletion is the 
commonest causes ofDMD account for the 60% ofDMD cases. 
Read et al., 1988 
2.2.3 Previous study 
Based on the deletion type of mutation, 98% can de detected by polymerase chain 
reaction (PCR). 
Beggs eta/., 1990; Chamberlain et al.,1990 
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